Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE: 002020)
China
· Delayed Price · Currency is CNY 11.05
-0.11 (-0.99%)
Sep 9, 2024, 1:43 PM CST
Zhejiang Jingxin Pharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 705.1 | 618.9 | 662.25 | 612.54 | 653.07 | 520.4 | Upgrade
|
| Depreciation & Amortization | 252.69 | 213.76 | 166.87 | 149.92 | 123.2 | 106.21 | Upgrade
|
| Other Amortization | 21.92 | 17.74 | 33.08 | 32.6 | 31.22 | 9.1 | Upgrade
|
| Loss (Gain) From Sale of Assets | -2.77 | -6.86 | -0.61 | 0.48 | 0.04 | 2.07 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.02 | 0.01 | 0.07 | 8.42 | 0.51 | 2.34 | Upgrade
|
| Loss (Gain) From Sale of Investments | -26.1 | -30.88 | -29.57 | -55.39 | -191.15 | -82.91 | Upgrade
|
| Provision & Write-off of Bad Debts | 15.01 | 6.73 | 3.64 | 10.8 | -1.81 | 2.26 | Upgrade
|
| Other Operating Activities | 38.11 | 15.63 | -1.3 | 22.77 | 19.09 | 18.09 | Upgrade
|
| Change in Accounts Receivable | -102.48 | -93.48 | -250.89 | -208.58 | 34.44 | -170.3 | Upgrade
|
| Change in Inventory | 87.54 | 123.04 | -102.95 | -152.51 | -82.69 | -60.13 | Upgrade
|
| Change in Accounts Payable | -126.63 | -74.58 | 387.41 | -41.84 | -103.68 | 188.3 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | -0.03 | 0.02 | Upgrade
|
| Operating Cash Flow | 855.83 | 792.84 | 855.78 | 373.46 | 513.21 | 535.3 | Upgrade
|
| Operating Cash Flow Growth | -13.98% | -7.35% | 129.15% | -27.23% | -4.13% | 2.36% | Upgrade
|
| Capital Expenditures | -309.57 | -519.51 | -515.57 | -406.83 | -334 | -337.33 | Upgrade
|
| Sale of Property, Plant & Equipment | 5.18 | 10.27 | 1.99 | 2.93 | 2.44 | 2.26 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -1.86 | Upgrade
|
| Investment in Securities | -1,356 | -260.2 | -342.4 | 508.33 | 707.69 | -29.31 | Upgrade
|
| Other Investing Activities | 17.27 | 31.85 | 118.32 | 37.86 | 87.8 | 152.04 | Upgrade
|
| Investing Cash Flow | -1,643 | -737.59 | -737.66 | 142.29 | 463.93 | -214.21 | Upgrade
|
| Long-Term Debt Issued | - | 585 | 236.54 | 146.16 | 297.6 | 348.96 | Upgrade
|
| Total Debt Issued | 735.72 | 585 | 236.54 | 146.16 | 297.6 | 348.96 | Upgrade
|
| Long-Term Debt Repaid | - | -568.33 | -166.05 | -320.64 | -358.76 | -155 | Upgrade
|
| Total Debt Repaid | -654.95 | -568.33 | -166.05 | -320.64 | -358.76 | -155 | Upgrade
|
| Net Debt Issued (Repaid) | 80.77 | 16.67 | 70.49 | -174.48 | -61.15 | 193.96 | Upgrade
|
| Issuance of Common Stock | - | - | - | 515.56 | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -200.99 | - | Upgrade
|
| Common Dividends Paid | -258.31 | -258.31 | -258.56 | -232.17 | -235.42 | -206.92 | Upgrade
|
| Other Financing Activities | -2.7 | -3.97 | 0.04 | 4.47 | 0.18 | -213.38 | Upgrade
|
| Financing Cash Flow | -180.24 | -245.61 | -188.03 | 113.38 | -497.38 | -226.34 | Upgrade
|
| Foreign Exchange Rate Adjustments | 4.52 | 2.71 | 14.87 | -3.75 | -9.95 | 1.78 | Upgrade
|
| Net Cash Flow | -963.22 | -187.65 | -55.05 | 625.38 | 469.81 | 96.53 | Upgrade
|
| Free Cash Flow | 546.26 | 273.32 | 340.2 | -33.37 | 179.21 | 197.97 | Upgrade
|
| Free Cash Flow Growth | 2.27% | -19.66% | - | - | -9.48% | -26.72% | Upgrade
|
| Free Cash Flow Margin | 12.97% | 6.84% | 9.00% | -0.96% | 5.50% | 5.43% | Upgrade
|
| Free Cash Flow Per Share | 0.63 | 0.32 | 0.40 | -0.04 | 0.23 | 0.23 | Upgrade
|
| Cash Income Tax Paid | 252.89 | 244.92 | 262.09 | 231.14 | 246.5 | 344.66 | Upgrade
|
| Levered Free Cash Flow | 294.44 | -85.08 | 312.3 | -204.19 | -31.16 | 271.11 | Upgrade
|
| Unlevered Free Cash Flow | 300.02 | -80.51 | 316.06 | -201.08 | -27.41 | 277.74 | Upgrade
|
| Change in Net Working Capital | 55.81 | 154.42 | -248.06 | 337.9 | 172.4 | -196.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.